Filing Flows › Cue Biopharma (CUE) › Q1 2026 › vs Q1 2025
Cue Biopharma (CUE) Q1 2026 vs Q1 2025 (year over year)
Cue Biopharma's revenue rose $5.3M (14×) from $421K in Q1 2025 to $5.7M in Q1 2026.
Cue Biopharma, Q1 2026: revenue $5.7M (14× year over year), operating margin -94.1%, net loss $5.2M, operating cash flow −$10.9M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $5.7M | $421K | $5.3M | 14× |
| Other income, net | $175K | $42K | $133K | +317% |
| Net loss | $5.2M | $12.3M | −$7.1M | -58% |
| Costs & expenses | $11.0M | $12.7M | −$1.7M | -13% |
| Operating costs | $11.0M | $12.7M | −$1.7M | -13% |
| Research & development | $6.9M | $8.5M | −$1.6M | -19% |
| General & admin | $4.2M | $4.2M | −$21K | -0.5% |
| Operating cash sources | $11.6M | $9.6M | $1.9M | +20% |
| Depreciation & amortization | $566K | $101K | $465K | +460% |
| Share-based compensation | $48K | $1.3M | −$1.3M | -96% |
| Cash used in operations | $10.9M | $8.2M | $2.8M | +34% |
| Net loss absorbed | $5.2M | $12.3M | −$7.1M | -58% |
| Working capital & other | $6.4M | −$2.6M | $9.0M | — |
Questions
How much did Cue Biopharma's revenue grow year over year in Q1 2026?
Cue Biopharma's revenue rose $5.3M (14×) from $421K in Q1 2025 to $5.7M in Q1 2026.